{"entity":{"type":"insider","cik":"0001909362","url":"/insider/0001909362","json_url":"/insider/0001909362.json","name":"Aslan Fred","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2025-08-18","last":"2026-05-19","span_basis":"filed_date"},"name_variants":[{"name":"Aslan Fred","source":"filing","n_filings":5,"first_seen":"2025-08-18","last_seen":"2026-05-19"}],"transactions":[{"id":6116454,"accession":"0001193125-26-231506","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-231506","line_url":"/filing/0001193125-26-231506#line-1","is_derivative":false,"issuer_cik":"0001817241","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001817241","owner_cik":"0001909362","owner_name":"Aslan Fred","owner_display_name":"Aslan Fred","owner_url":"/insider/0001909362","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27116.0,"shares_display":"27,116","price_per_share":9.0077,"price_display":"9.01","price_state":"stated","total_value":244252.7932,"total_display":"244,252.79","total_whole":"244,253","shares_owned_after":1535082.0,"shares_owned_after_display":"1,535,082","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-19","filed_date":"2026-05-19","scope":"insider"},{"id":4906726,"accession":"0001193125-25-319696","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-25-319696","line_url":"/filing/0001193125-25-319696#line-1","is_derivative":false,"issuer_cik":"0001817241","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001817241","owner_cik":"0001909362","owner_name":"Aslan Fred","owner_display_name":"Aslan Fred","owner_url":"/insider/0001909362","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3187.0,"shares_display":"3,187","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":19122.0,"total_display":"19,122.00","total_whole":"19,122","shares_owned_after":1209948.0,"shares_owned_after_display":"1,209,948","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-15","filed_date":"2025-12-15","scope":"insider"},{"id":4623844,"accession":"0001193125-25-285004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-25-285004","line_url":"/filing/0001193125-25-285004#line-2","is_derivative":false,"issuer_cik":"0001817241","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001817241","owner_cik":"0001909362","owner_name":"Aslan Fred","owner_display_name":"Aslan Fred","owner_url":"/insider/0001909362","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6375.0,"shares_display":"6,375","price_per_share":3.376,"price_display":"3.38","price_state":"stated","total_value":21522.0,"total_display":"21,522.00","total_whole":"21,522","shares_owned_after":343999.0,"shares_owned_after_display":"343,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-17","filed_date":"2025-11-17","scope":"insider"},{"id":4972774,"accession":"0001909362-25-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001909362-25-000004","line_url":"/filing/0001909362-25-000004#line-1","is_derivative":false,"issuer_cik":"0001817241","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001817241","owner_cik":"0001909362","owner_name":"Aslan Fred","owner_display_name":"Aslan Fred","owner_url":"/insider/0001909362","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25500.0,"shares_display":"25,500","price_per_share":6.0,"price_display":"6.00","price_state":"stated","total_value":153000.0,"total_display":"153,000.00","total_whole":"153,000","shares_owned_after":356721.0,"shares_owned_after_display":"356,721","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-17","filed_date":"2025-10-17","scope":"insider"},{"id":4953212,"accession":"0001415889-25-022224","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-25-022224","line_url":"/filing/0001415889-25-022224#line-3","is_derivative":false,"issuer_cik":"0001817241","issuer_name":"Artiva Biotherapeutics, Inc.","issuer_ticker":"ARTV","issuer_name_source":null,"issuer_url":"/issuer/0001817241","owner_cik":"0001909362","owner_name":"Aslan Fred","owner_display_name":"Aslan Fred","owner_url":"/insider/0001909362","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25500.0,"shares_display":"25,500","price_per_share":2.7286,"price_display":"2.73","price_state":"stated","total_value":69579.3,"total_display":"69,579.30","total_whole":"69,579","shares_owned_after":386693.0,"shares_owned_after_display":"386,693","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-15","filed_date":"2025-08-18","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001817241","name":"Artiva Biotherapeutics, Inc.","url":"/issuer/0001817241","role":"Director, Officer (Chief Executive Officer)","n_filings":5,"first_seen":"2025-08-18","last_seen":"2026-05-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001909362","retrieved_at":"2026-08-23T07:44:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}